Showing results (141-150 of 549) with videos related to
Sort By:
Pageof 55
International Journal of Colorectal Disease|June 9, 2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.European Journal of Cancer & Clinical Oncology|May 1, 1984
A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classificationsS Monfardini, F Rilke, P Valagussa, et al.Oncology Reports|May 10, 2007
Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?A Martinetti, C Ripamonti, R Miceli, et al.Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.Cancer|December 1, 1993
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinomaM Colleoni, R Buzzoni, E Bajetta, et al.Anticancer Research|January 29, 2000
Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's diseaseF Villani, I Dell'Oca, P De Maria, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year resultsS Viviani, G Bonadonna, A Santoro, et al.Clinical Epigenetics|September 1, 2019
Particulate matter exposure shapes DNA methylation through the lifespanL Ferrari, M Carugno, V BollatiMinerva Ginecologica|November 9, 2004
[Spontaneous uterine rupture in the third trimester of gestation after laparoscopic myomectomy. A case report]S Malberti, L Ferrari, R MilaniAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphomaR Buzzoni, M Colleoni, E Bajetta, et al.Pageof 55